Emergent BioSolutions

Emergent BioSolutions Inc. is an American multinational specialty <a href="/facts/Biopharmaceutical/FHk7EwkH">biopharmaceutical</a> company headquartered in <a href="/facts/Gaithersburg,_Maryland/NU2ItqFm">Gaithersburg, Maryland</a>. It develops <a href="/facts/Vaccine/QcXzLug2">vaccines</a> and <a href="/facts/Antibody/MX8pdTdP">antibody</a> <a href="/facts/Therapy/2ytkGbgT">therapeutics</a> for infectious diseases and <a href="/facts/Opioid/EGnE2x99">opioid</a> overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial <a href="/facts/BioThrax/EgyV7YvK">BioThrax</a> (Anthrax Vaccine Adsorbed), the only <a href="/facts/Anthrax/svk0t5G4">anthrax</a> vaccine licensed by the <a href="/facts/Food_and_Drug_Administration/rCEnh9WB">U.S. Food and Drug Administration</a> (FDA) and Narcan (<a href="/facts/Naloxone/M2GxfKzL">naloxone</a>) for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the <a href="/facts/COVID-19_pandemic/0xTsh7Ut">COVID-19 pandemic</a>, Emergent BioSolutions also produced <a href="/facts/Janssen_COVID-19_vaccine/a6ePrE7M">Johnson & Johnson/Janssen</a> and <a href="/facts/Oxford%E2%80%93AstraZeneca_COVID-19_vaccine/1DF8upN8">Oxford–AstraZeneca</a> vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded.

Emergent BioSolutions open-in-new

Emergent BioSolutions